SUNNYVALE, Calif., Oct. 21 /PRNewswire/ -- Biocircuits Corporation
(Nasdaq: BIOC) today announced that Thomas P. Hartz, Ph.D. has joined the
company as Vice President of Research and Development. Dr. Hartz holds a
Ph.D. in chemistry and has 18 years of experience in the diagnostic industry.
His experience includes Miles Laboratories, Dupont Medical Products and most
recently as Vice President of Biometric Imaging, Dr. Hartz replaces Larry
Blecka who recently left the company.
"We are pleased to attract an individual with a strong track record of
success in developing complete systems that involve chemistry, electronics and
optics," stated John Kaiser, President and CEO. "The experience that Tom
brings to the Company will allow us to move forward in development of now
assays and the continual upgrade of the IOS(R) system," Mr. Kaiser further
stated.
The Company also announced that James Welch was promoted to the position
of Vice President and Chief Financial Officer. Mr. Welch has a BA in Business
Administration from Whitworth College, an MBA from Washington State University
and has worked in the high tech industry since 1982. Mr. Welch was Corporate
Controller of Biocircuits prior to his promotion and he replaces Donald
Hawthorne who previously left the company.
Biocircuits has developed and currently markets an inexpensive and easy to
use immunoassay system for point of care testing.
SOURCE Biocircuits Corporation
 back to top
CONTACT:
John Kaiser, President & CEO, 408-752-8706,
or James Welch, CFO, 408-752-8728, both of Biocircuits
Corporation
|
